GlassScriptPhysician profile
Richmond Laryea
NPI 1811579097
$4,512.46
in general payments reported to CMS, 2019-2025
8 companies · $1,227 in 2025
The $1,227 reported for 2025 was more than what 90% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $27.56 · 2024: $3,258 · 2025: $1,227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,410 · Travel and Lodging: $2,075.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,409.98 |
| Travel and Lodging | $2,074.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,004.21 | 2024 | Na, Smartlock |
| Abbvie INC. | $986.56 | 2024-2025 | |
| Inspire Medical Systems, INC. | $644.69 | 2024-2025 | Inspire |
| Axogen | $477.20 | 2025 | |
| Depuy Synthes Sales INC. | $235.27 | 2025 | Matrixcombo, Trumatch |
| Neurent Medical Limited | $74.32 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Olympus America INC. | $62.65 | 2024-2025 | Rhino-Laryngo Videoscope |
| Karl Storz Endoscopy-America | $27.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richmond Laryea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.